Benjamin Otto
Impact in
- Hepatology top 5%
- Hepatitis Viruses Studies and Epidemiology
- Hepatitis C virus research
- Liver Diseases and Immunity
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
-
- Hepatitis C virus research 2
- Liver Diseases and Immunity 2
-
- MicroRNA in disease regulation 3
- Breast Cancer Treatment Studies 2
- Co-authors
- Thomas Streichert (16 shared papers)Ansgar Wilhelm Lohse (4 shared papers)Sven Pischke (3 shared papers)Kathy L. Woolson (1 shared paper)Eik Vettorazzi (1 shared paper)Harry R. Dalton (1 shared paper)Glynn W. Webb (1 shared paper)Levente Kriston (1 shared paper)
- Journals
- PLoS ONE (4 papers)International Journal of Cancer (3 papers)BMC Cancer (2 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (2 papers)Journal of Hepatology (2 papers)
- Partner nations
- GermanySwitzerlandUnited Kingdom
In The Last Decade
Benjamin Otto
36 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 84
- Hepatology 291
- Cancer Research 124
- Oncology 135
- Physiology 139
- Nephrology 38
Countries citing papers authored by Benjamin Otto
This map shows the geographic impact of Benjamin Otto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Otto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Otto more than expected).
Fields of papers citing papers by Benjamin Otto
This network shows the impact of papers produced by Benjamin Otto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Otto. The network helps show where Benjamin Otto may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Otto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 196 | |
| 2 | 2010 | 113 | |
| 3 | 2011 | 68 | |
| 4 | 2012 | 55 | |
| 5 | 2011 | 53 | |
| 6 | 2014 | 47 | |
| 7 | 2010 | 44 | |
| 8 | 2015 | 42 | |
| 9 | 2016 | 39 | |
| 10 | 2013 | 33 | |
| 11 | 2013 | 30 | |
| 12 | 2016 | 30 | |
| 13 | 2014 | 26 | |
| 14 | 2015 | 24 | |
| 15 | 2017 | 23 | |
| 16 | 2010 | 22 | |
| 17 | 2018 | 22 | |
| 18 | 2012 | 21 | |
| 19 | 2016 | 20 | |
| 20 | 2016 | 19 |
About Benjamin Otto
Benjamin Otto is a scholar working on Hepatology, Cancer Research, Oncology, Physiology and Pathology and Forensic Medicine, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Clinical Laboratory Practices and Quality Control (3 papers), Cancer Cells and Metastasis (3 papers), MicroRNA in disease regulation (3 papers), Hepatitis C virus research (2 papers), Breast Cancer Treatment Studies (2 papers), Liver Diseases and Immunity (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Lysosomal Storage Disorders Research (1 paper). The work is most often cited by research in Hepatology (291 citations), Cancer Research (124 citations), Oncology (135 citations), Physiology (139 citations) and Nephrology (38 citations). Benjamin Otto has collaborated with scholars based in Germany, Switzerland and United Kingdom. Frequent co-authors include Thomas Streichert, Ansgar Wilhelm Lohse, Sven Pischke, Kathy L. Woolson, Eik Vettorazzi, Harry R. Dalton, Glynn W. Webb, Levente Kriston, Johannes Hartl and Richie G. Madden. Their work appears in journals such as PLoS ONE, International Journal of Cancer, BMC Cancer, Clinical Chemistry and Laboratory Medicine (CCLM) and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.